Cooper Pharma Limited - Company Profile

Q: Who are the current directors of Cooper Pharma Limited?

The current directors of Cooper Pharma Limited are Rakesh Bhargava, Dinesh Kumar, Abhishek Bhargava.

It is a pharma public limited company based in Delhi, Delhi, India, established in 1989.

1989 Delhi, Delhi, India Active

Last Updated: December 23, 2025

About Cooper Pharma Limited

Cooper Pharma Limited, a active public limited company, was established on 02 February 1989 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1989PLC034902. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.00 Cr.

Formerly known as Cooper Pharma Private Limited. It upholds a compliant status. Employing 122 professional, Its leadership includes Rakesh Bhargava (Managing Director), Dinesh Kumar (Director), Abhishek Bhargava (Whole-Time Director). Past directors included Rakesh Bhargava, Lata Bhargava, Abhijit Sengupta. It holds ₹3.03 Cr open charges and ₹22.60 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. - 5, Nidhi Plaza - Ii, 2Nd Floor,, L.S.C. Gulabi Bagh, Delhi, Delhi, 110052.

Company Details

CIN/LLPIN
U24231DL1989PLC034902
Registration Number
034902
Incorporation Date
02 February 1989
Authorized Capital
₹3.00 Cr
Paid-Up Capital
₹1.00 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.00 Cr as on 23-12-2025
Paid Up Capital ₹ 1.00 Cr as on 23-12-2025
Company Age 37 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 3.03 Cr as on 23-12-2025
Satisfied Charges ₹ 22.60 Cr as on 23-12-2025

Comprehensive Company Insights

Explore comprehensive insights into Cooper Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cooper Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rakesh Bhargava	Managing Director	02 Feb 1989	Current
Dinesh Kumar	Director	05 Jun 2024	Current
Abhishek Bhargava	Whole-Time Director	01 Aug 2009	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Oct 2009	Past
Pramod Abcsdd	Director	24 Dec 2013	Past
Pramod Abcsdd	Director	21 May 2019	Past
Pramod Abcsdd	Additional Director	29 Oct 2020	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Director	30 Sep 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cooper Pharma.

Cooper Pharma Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cooper Pharma?

In 2024, Cooper Pharma had a promoter holding of 99.81% and a public holding of 0.19%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹30,250,000.00

Satisfied Charges

₹225,990,000.00

Charges Breakdown by Lending Institutions

Small Industries Developmnt Bank Of India : 3.00 Cr
Punjab National Bank : 0.03 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Apr 2011	Punjab National Bank	₹0.25 M	Open
28 Mar 2006	Small Industries Developmnt Bank Of India	₹3.00 Cr	Open
02 Apr 2025	Others	₹12.50 Cr	Satisfied
04 Jul 2018	Others	₹0.99 M	Satisfied
13 Feb 2015	Dbs Bank Ltd.	₹5.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cooper Pharma?

Cooper Pharma has a workforce of 122 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cooper Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cooper Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cooper Pharma

Recent Activity within the Organization

Annual General Meeting

Cooper Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Charges

Progress on A charge registered on 02 Apr 2025 via Charge ID 101073359 with Others was fully satisfied on 15 Sep 2025. was documented.
15 Sep 2025
Charges

A charge with Others amounted to Rs. 12.50 Cr with Charge ID 101073359 was registered on 02 Apr 2025. was recorded as a recent event.
02 Apr 2025
Balance Sheet

Cooper Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
31 Mar 2025
Charges

Progress on A charge registered on 04 Jul 2018 via Charge ID 100232370 with Others was fully satisfied on 11 Mar 2025. was documented.
11 Mar 2025
Director Appointment

The activity Dinesh Kumar was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 1 year 9 months . was completed.
05 Jun 2024

Explore recent activity and updates - View Recent Activity